<div class="white-sheet">
	<div class="content-slide">

		<div class="title-bar red"></div>

		<div class="wrapper slide-2-6-2-5">

			<div class="popups" style="position:absolute">
				<div data-effect="fade" data-duration="1000" data-target="references-overlay" data-width="600" data-height="490" class="references-button show-overlay"></div>	
			</div>

			<div class="slide-title red">
				Treatment of relapsed severe aplastic anaemia 
			</div>


			<div class="content-container">
				
				<ul>
					<li><span>There is no consensus on the definition of relapse in severe aplastic anaemia<sup>1</sup></span>
						<ul>
							<li><span>Reintroduction of IST is required for decreasing blood counts, with or without restarting blood product transfusions<sup>1</sup></span></li>
						</ul>
					</li>
					<li><span>In relapsed cases, response rates to r-ATG/CsA are 68% at 6 months<sup>2</sup></span>
						<ul>
							<li><span>Reintroduction or an increase in CsA dose for 2–3 months is a simple way of treating relapse<sup>1</sup></span></li>
						</ul>
					</li>
					<li><span>Treatment may be continued until blood counts improve (at least 6–12 months), after which the CsA dose may be tapered off<sup>1</sup></span>
						<ul>
							<li><span>However, a gradual decline in blood counts may occur with the taper<sup>3</sup></span></li>
							<li><span>The aim is to use the lowest possible dose of CsA to maintain adequate blood counts<sup>3</sup></span>
								<ul>
									<li><span>However, the patient may become increasingly intolerant to treatment as blood counts continue to deteriorate<sup>3</sup></span></li>
								</ul>
							</li>
						</ul>
					</li>
					<li><span>When a haematological response is not achieved with IST and severe pancytopenia persists, transplant options must be pursued<sup>1</sup></span></li>
				</ul>

			</div>

		</div>


		<div class="references-overlay overlay">

			<header>References</header>
				
			<ol>
				<li class="navigateHref" data-navtarget="media/documents/module2/ScheinbergP-2012-Blood-v120p1185.pdf"><span>Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185</span></li>
				<li class="navigateHref" data-navtarget="media/documents/module2/ScheinbergP-2006-BrJHaematol-v133p622.pdf"><span>Scheinberg P <i>et al. Br J Haematol</i> 2006;133:622</span></li>
				<li class="navigateHref" data-navtarget="media/documents/module2/ScheinbergP-2012-HematologyAmSocHematolEducPogram-v2012p292.pdf"><span>Scheinberg P <i>et al. Hematology Am Soc Hematol Educ Program</i> 2012;292</span></li>
			</ol>

		</div>

	</div>
</div>